15 September 2023
Current Oncology | World Lymphoma Awareness Day in 2023—“We Can’t Wait”

World Lymphoma Awareness Day (WLAD) takes place annually on September 15th. It is organized by the Lymphoma Coalition and was established in 2004 with the purpose of promoting public understanding of the various subtypes of lymphoma. Its primary objectives include educating people about recognizing symptoms, encouraging early diagnosis, and emphasizing the importance of timely treatment.

For World Lymphoma Awareness Day 2023, Current Oncology (ISSN: 1718-7729) has gathered open access academic research on the topic of lymphoma. We hope to share new scientific knowledge in the field of lymphoma with the world on this special day.

1. “CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen”
by John J. Schmieg, Jeannie M. Muir, Nadine S. Aguilera and Aaron Auerbach
Curr. Oncol. 2021, 28(6), 5124–5147;
Available online:

2. “How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen”
by José Cabeçadas, Victor E. Nava, Joao L. Ascensao and Maria Gomes da Silva
Curr. Oncol. 2021, 28(6), 4611–4633;
Available online:

3. “A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma”
by Elif Yilmaz, Arashpreet Chhina, Victor E. Nava and Anita Aggarwal
Curr. Oncol. 2021, 28(6), 5148–5154;
Available online:

4. “Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma”
by Rami Abdulbaki, Parastou Tizro, Victor E. Nava, Maria Gomes da Silva and João L. Ascensão
Curr. Oncol. 2021, 28(6), 4821–4831;
Available online:

5. “Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology”
by Evgenii Shumilov, Paolo Mazzeo, Martin S. Zinkernagel, Myriam Legros, Naomi Porret, Lorenz Romagna, Detlef Haase, Georg Lenz, Urban Novak, Yara Banz et al.
Curr. Oncol. 2022, 29(2), 766–776;
Available online:

6. “Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement”
by Thomas Breakell, Heidi Waibel, Stefan Schliep, Barbara Ferstl, Michael Erdmann, Carola Berking and Markus V. Heppt
Curr. Oncol. 2022, 29(5), 2909–2919;
Available online:

7. “Management of Marginal Zone Lymphoma: A Canadian Perspective”
by Anthea Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette and Anca Prica
Curr. Oncol. 2023, 30(2), 1745–1759;
Available online:

8. “Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada”
by Graeme Ball, Christopher Lemieux, David Cameron and Matthew D. Seftel
Curr. Oncol. 2022, 29(3), 2021–2045;
Available online:

9. “Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma”
by Randeep Sangha, Neal M. Davies, Afshin Namdar, Michael Chu, Jennifer Spratlin, Erwan Beauchamp, Luc G. Berthiaume and John R. Mackey
Curr. Oncol. 2022, 29(3), 1939–1946;
Available online:

10. “Novel Mutations in a Lethal Case of Lymphomatous Adult T Cell Lymphoma with Cryptic Myocardial Involvement”
by Taraneh Hashemi Zonouz, Rami Abdulbaki, Bidhan C. Bandyopadhyay and Victor E. Nava
Curr. Oncol. 2021, 28(1), 818–824;
Available online:

More News...
Back to TopTop